FreeThink Technologies is a science-based company conducting experimental work to help clients develop drug products. FreeThink has specific expertise in stability (shelf life) and formulation development and licenses its advanced accelerated stability software ASAPprime®. FreeThink also produces OzmoCAP® extended-release capsules providing a range of release durations, independent of drug properties. For more information, visit https://freethinktech.com/

DIANT Pharma provides award-winning continuous processing technology and services, applicable for nanoparticle drug products and vaccines. Our process is based on an end-to-end adaptable, high-throughput and fully automated system that reduces the number of batches, processing steps, and facility size requirements by 70-90%. Learn more at www.diantpharma.com.

Xeris, headquartered in Chicago, is a commercial stage biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products utilizing its proprietary ultra-concentrated (>400mg/mL), ready-to-use, injectable formulation platforms XeriSol ™ and XeriJect™. Xeris has established multiple XeriJect™ partnerships for biologics and actively seeks to license its formulation platforms.” Learn more at https://www.xerispharma.com/research-development/technology

Pendant Biosciences is an advanced materials biotech developing a proprietary biodegradable polymer technology utilizing cross-linked pendant functionalized polymers. This next-generation polymer system overcomes many of the limitations of older PLGA-based systems, is highly tunable and creates innovative long-acting injectable formulations for systemic and localized delivery. To learn more visit https://pendantbio.com/

SEQENS is a worldwide leader in the development and production of active ingredients, pharmaceutical intermediates, specialty & personal care ingredients leveraging 24 manufacturing sites, 10 R&D centers and 3,400 employees in 10 countries. As an integrated player across the value chain, SEQENS develops and industrializes the most demanding molecules, and relies on its ability to innovate and implement the best available technologies. To learn more, please visit www.seqens.com

DCA is one of the world’s leading product design consultancies, with an exceptional record of developing drug delivery devices from strategy, through technical delivery, to market success. We can provide expert support for device strategy, due diligence, mechanical engineering, connectivity, medical device software, electronics, usability, industrial design, industrialisation support, packaging and instruction design. To learn more, visit https://www.dca-design.com/

OnDosis is an AstraZeneca spinout addressing individualized and connected treatments through its proprietary drug delivery technology for oral solid drugs. The technology enables precise and flexible dosing in the patient’s home environment through a connected handheld device with associated digital solution, also supporting adherence and remote patient monitoring. To learn more, visit https://www.ondosis.com/

Windgap Medical is imagining the future of reconstitution devices. Our autoinjector platforms simplify, automate, and speed up the delivery of difficult-to-mix drugs, freeing patients, families, and potential cures from the limitations of current medical delivery technology. We are a proud industry leader in self-administration devices that consider the needs of patients first when delivering complex injectables. To learn more, visit https://windgapmedical.com/

We are a Canadian contract development and manufacturing organization (CDMO) specializing in the production of nucleic acid and lipid products that support life-enabling work. We strive towards this daily by developing and deploying our state-of-the-art bioprocessing and chemical process technologies, using proprietary manufacturing and analytical approaches, employing a highly skilled workforce, and partnering with an excellent and extensive network of relationships and collaborations. We support our customers by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field. We are dedicated to supporting our customers by providing scalable manufacturing capacity and accelerating innovation in bringing their products from the benchtop to real-world applications.

Our goal is to accelerate pre-clinical development time for long-acting injectables through automation and machine learning. This reduces time-to-market for our pharma customers and enables them to improve patient compliance & quality-of-life. Persist is currently seeking collaborators who’d like a formulation for their API, as a case-study. To learn more, please visit https://www.persist-ai.com/

Lokavant is a clinical trial intelligence platform that improves trial planning and execution performance through data-driven analytics. Lokavant’s platform aggregates and integrates real-time data from disparate trial data sources, and powers advanced analytics enabled by its compendium of proprietary trial data. To learn more visit www.lokavant.com

Eko Health advances how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform allows professionals to detect earlier and more accurately, diagnose more confidently, manage treatment effectively, and give patients the best care possible. To learn more, visit www.ekohealth.com